Mahmoud Ameri PhD

Dr. Ameri is one of the co-founders of Zosano Pharma and brings 20 years of drug delivery, preclinical and early ex U.S. clinical development of combination products to the company. He is responsible for research and development. Prior to Zosano, he was at Alza/J&J were he co-invented and developed the Adhesive Dermally Applied Microarray system and holds over 20 patents and patent applications all relating to the Zosano drug delivery technology. Dr. Ameri received his Ph.D. from the School of Pharmacy at the University of Manchester in the United Kingdom.